Literature DB >> 9753714

Treatment of breast cancer.

G N Hortobagyi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9753714     DOI： 10.1056/NEJM199810013391407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  143 in total

1.  Docetaxel induced cardiotoxicity.

Authors:  M Shimoyama; Y Murata; K I Sumi; R Hamazoe; I Komuro
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

2.  Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.

Authors:  O W Nielsen; J Hilden; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

3.  Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.

Authors:  N P Gall; M T Kearney; A Zaman; S O'Nunain; K A Fox; A Flapan; J Nolan
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

4.  Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.

Authors:  C Berry; N Anderson; A J Kirk; A F Dominiczak; J J McMurray
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

5.  Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.

Authors:  Christina Reufsteck; Rinat Lifshitz-Shovali; Michael Zepp; Tobias Bäuerle; Dieter Kübler; Gershon Golomb; Martin R Berger
Journal:  Clin Exp Metastasis       Date:  2012-03-11       Impact factor: 5.150

6.  Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer.

Authors:  Mónica Fernández-Sánchez; Armando Gamboa-Dominguez; Norma Uribe; Ana Cristina García-Ulloa; Diana Flores-Estrada; Myrna Candelaria; Oscar Arrieta
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

7.  The efficacy of second-line hormone therapy for recurrence during adjuvant hormone therapy for breast cancer.

Authors:  Ryutaro Mori; Yasuko Nagao
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

Review 8.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

Review 9.  Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.

Authors:  Avinash Gothwal; Iliyas Khan; Umesh Gupta
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

10.  Significance of age-associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan.

Authors:  Koji Takada; Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Tamami Morisaki; Katsuyuki Takahashi; Masatsune Shibutani; Ryosuke Amano; Tsutomu Takashima; Shuhei Tomita; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.